Author

Pearlie K. Burnette

Observed names: P. K. Burnette, P.K. Burnette, Pearlie Burnette, Pearlie K Burnette, Pearlie Kay Burnette

Observed institutions: University of South Florida, University of Florida Health, AbbVie (United States), Moffitt Cancer Center, University of Florida, James A. Haley Veterans' Hospital

OpenAlex ID: A5081368639

Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.

2002 · Ramadevi Nimmanapalli, Erica O'Bryan, et al. · PubMed · 111

Functional association of TGF-β receptor II with cyclin B

1999 · Jin Hong Liu, Sheng Wei, et al. · Oncogene · 43

Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL)

2020 · Rami S. Komrokji, Najla al Ali, et al. · Leukemia · 24

Parenteral Ondansetron for the Treatment of Chemotherapy‐ and Radiation‐Induced Nausea and Vomiting

1992 · P.K. Burnette, Janelle Perkins · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 13

Rifampin-Associated Thrombocytopenia Secondary to Poor Compliance

1989 · Pearlie K. Burnette, Barbara Ameer, et al. · DICP · 8

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

2007 · Sheng Wei, Kathy Rocha, et al. · Blood · 7

Characterization of Myelodysplastic Syndromes (MDS) with T-Cell Large Granular Lymphocyte Proliferations (LGL)

2016 · Christa Roe, Najla Alali, et al. · Blood · 4

Pancytopenia Secondary to Short-Term, High-Dose Intravenous Infusion of Amrinone

1990 · Paul M. Mattingly, P.K. Burnette, et al. · DICP · 4

Abstract LB-249: HDAC11 regulates lysine acetylation of enolase 1

2018 · Vasundhara Sharma, Agni Christodoulidou, et al. · Cancer Research · 2

Dysregulation of TGF-Beta Stimulated Smad Signaling Is Seen in Myelodysplasia and Points to the Potential Therapeutic Efficacy of TGF-Beta Receptor I Kinase Inhibition in Low Grade Disease.

2009 · Li Zhou, Christine McMahon, et al. · Blood · 2

Abstract 1227: Immune modulatory effect of pramlintide for cutaneous squamous cell carcinoma treatment

2019 · Leticia Tordesillas, Rebecca Hesterberg, et al. · Cancer Research · 1

Abstract 3439: Interaction between cutaneous human papillomavirus infection and telomere length in association with cutaneous squamous cell carcinoma

2016 · Shalaka S. Hampras, Michael Pawlita, et al. · Cancer Research · 1

39 Myeloid-derived suppressor cells (MDSC) are effectors of bone marrow suppression in lower risk myelodysplastic syndromes (MDS)

2011 · S. Wei, X. Chen, et al. · Leukemia Research · 1

Abstract C042: TOP1i-ADC demonstrates immune-stimulating activity in colorectal cancer explants

2026 · Durga B Dandamudi, Irene I Lee, et al. · Cancer Immunology Research

Abstract 1227: Immune modulatory effect of pramlintide for cutaneous squamous cell carcinoma treatment

2019 · Leticia Tordesillas, Rebecca Hesterberg, et al. · Experimental and Molecular Therapeutics

Abstract 4960: Recent ultraviolet radiation exposure and circulating immunosuppressive T-regulatory cells

2017 · Dana E. Rollison, Shalaka S. Hampras, et al. · Cancer Research

Intrapatient Functional Clonality Deconvoluted By Coupling Intracellular Flow Cytometry and Next Generation Sequencing in Human Leukemia

2016 · Qing Zhang, Markus Ball, et al. · Blood

Telomere length, cutaneous beta human papillomavirus infection and cutaneous squamous cell carcinoma

2016 · Shalaka Hampras, Michael Pawlita, et al. · Dermatology Online Journal

PDF

Abstract A86: Harnessing T-cell homeostasis to diagnose and treat solid and liquid tumors

2015 · Mark Robertson-Tessi, Derek Park, et al. · Cancer Immunology Research

Impact of MICA and Other Immunogenetic Polymorphisms On Clinical Presentation of T Cell Large Granular Lymphocyte Leukemia.

2009 · Aleksandr Lazaryan, Nelli Bejanyan, et al. · Blood

Works count: 20

Citation count: 221

H-index: 6

I10-index: 4